Dr. Wosiski-Kuhn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Wake Forest School of Medicine
Winston Salem, NC 27101- Is this information wrong?
Education & Training
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2017
Publications & Presentations
PubMed
- 13 citationsInterleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients.Marlena Wosiski-Kuhn, James Caress, Michael S. Cartwright, Gregory A. Hawkins, Carol Milligan> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2021 Apr 3
- 18 citationsIL6 receptor358Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis.Marlena Wosiski-Kuhn, Mac B. Robinson, Jane L. Strupe, Phonepasong Arounleut, Matthew Martin, James Caress, Michael Cartwright, Robert Bowser, Merit Cudkowicz, Carl D....> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2019 Oct 14
- 11 citationsA pilot study of neuromuscular ultrasound as a biomarker for amyotrophic lateral sclerosis.Sapna Pathak, James B. Caress, Marlena Wosiski-Kuhn, Carol Milligan, Delaney Williams, Michael S. Cartwright> ;Muscle & Nerve. 2019 Feb 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
